Where does Trace Genomics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Trace Genomics, Inc. ranks #33,655 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Trace Genomics, Inc. hold?

Trace Genomics, Inc. holds 8 US utility patents granted between 2019 and 2025, spanning 10 technology areas.

What is Trace Genomics, Inc.'s Innovation Score?

Trace Genomics, Inc. has an Innovation Score of 44.9 out of 100 (top 24% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Trace Genomics, Inc.'s patent grant rate increasing or decreasing?

Trace Genomics, Inc.'s recent grant velocity is +500% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Trace Genomics, Inc.'s patents?

Trace Genomics, Inc.'s patents average 15.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Trace Genomics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Trace Genomics, Inc.

Q: What technology areas does Trace Genomics, Inc. focus on?

Trace Genomics, Inc.'s top technology area is G16B (Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology) with 6 patents. Grants appear in 10 CPC subclasses total.

USPTO PatentsView assignee record - 8 granted patents across 10 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G16B (Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Trace ranks #33,655 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 10 technology areas.

#33,655
of 49,997 US assignees by volume: Top 24%
by Innovation Score (44.9/100): 15.8
avg claims per patent: +500%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R33655 · US Corporation #33,655 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 8 grants
MID-PACK #33,655/49,997
PHOTO-FINISH Topharman Shanghai
CPC-FOCUS G16B · 10 areas
INNOV-PAR 44.9/100
CLAIMS-RICH 15.8 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +500% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Topharman Shanghai Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Trace Genomics · this assignee

45
3D Lighting… · lowest

7

What this shows Trace's Innovation Score is 44.9/100 (top 24% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Trace's grants concentrate

Trace Genomics, Inc. is a focused PatentsView assignee: 10 CPC subclasses with 75% of grants classified under G16B (Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology). Peak complete grant year is 2022 (2 grants) versus a trough of 1 in 2019. By volume, Trace sits between Topharman Shanghai Co., Ltd. and Trioptotec GMBH.

Trace's three-year grant acceleration

Trace Genomics, Inc. shows 5 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Topharman Shanghai

8
Topnir Systems SAS

8
Toshiba Alpine Au…

8
Totoku Electric

8
Transmisiones Y E…

8
Tree SAP Farms

8
TRI Tool

8
Trioptotec

8
Trace Genomics ◀

8

What this shows Trace holds 8 patents at rank #33,567, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Trace

By rank, the assignees closest to #33,567 in granted patent volume.

Leaders in G16B (Bioinformatics)

Other assignees with the most granted patents in Trace's primary technology class.

Trace's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

45 Top 24% higher than 76% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Trace Genomics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	1	12.5%
2020	1	12.5%
2022	2	25.0%
2023	1	12.5%
2024	2	25.0%
2025partial year	1	12.5%

Which technologies does Trace Genomics, Inc. patent most?

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 6

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 5

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 5

G01S - Radio DIRECTION-FINDING; Radio NAVIGATION; Determining Distance OR Velocity BY USE OF Radio WAVES; Locating OR Presence-detecting BY USE OF THE Reflection OR Reradiation OF Radio WAVES; Analogous Arrangements Using Other Waves 2

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 2

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 2

A01B - Soil Working IN Agriculture OR FORESTRY; Parts, Details, OR Accessories OF Agricultural Machines OR Implements, IN General 1

G06N - Computing Arrangements Based ON Specific Computational Models 1

Y02A - Technologies FOR Adaptation TO Climate Change 1

G06F - Electric Digital Data Processing 1

Top 10 of 10 technology areas

Where it ranks

Overall rank by patents

#33,655

of 49,997 tracked assignees

Innovation Score

44.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Trace Genomics, Inc.'s patent record in context - here's where to go next.

Trace Genomics, Inc.'s lead technology class is G16B (Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology), 75% of its portfolio - see every assignee active in that class. Explore G16B
Ranked #33,655 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Trace Genomics, Inc. against Topharman Shanghai Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 44.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.